drugset / Trial / NCT02217930
Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers
RandomizedCrossoverTriple-blind
Summary
The study designed to determine the effect induced by WCK 2349 on the QT interval. The study will be conducted in two parts: 1) to determine the supratherapeutic dose; and 2) to assess the safety of high doses of single-dose administration of WCK 2349 on the QT interval.
Timeline
- Start
- 2014-08
- Primary completion
- 2014-12
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | WCK 2349 | Unknown | 1800 mg | Oral |
| Subject | WCK 2349 | Unknown | 2200 mg | Oral |
| Subject | WCK 2349 | Unknown | 2600 mg | Oral |
| Subject | WCK 2349 | Unknown | 3000 mg | Oral |